- Sheba Medical Center is creating the world-first first VR-based hospital by leverage XRHealth’s virtual reality platform as part of their strategic innovation commitment to digital health. - Sheba will leverage XRHealth’s VR platform for cognitive therapy, physical therapy, pain relief, and many other applications throughout the entire hospital.Sheba Medical Center, the leading medical center in the Middle East and an internationally recognized healthcare facility in Israel, today announced a
Read More
Alzheimer’s disease
Boston U Launches First-Ever Virtual Alzheimer’s Disease Population Health Study
- Savonix and Boston University School of Public Health launches the first-ever population health Alzheimer’s Disease Discovery Study (ASSIST) to digitally collect brain health data from over 400k participants.- First-ever wholly digital population health study that captures data from multiple wearable technologies together with sensitive neuropsychology tests to examine how risks for dementia cluster to produce diseases like Alzheimer’s.- Study data will power first time knowledge of how
Read More
Papa Raises $10M to Expand “Grandkids on Demand” Platform to Address Social Isolation in Seniors
- Papa raises $10M in Series A funding to expand “grandkids on-demand” platform to help reduce social isolation in seniors. - Adds partnerships with multiple large health insurance plans, including Humana, Aetna, Priority Health and Alignment Healthcare. - Papa will use the funding to expand its services to a broader population of older adults, via partnerships with additional insurance plans and employee benefits provider.Papa, a digital health company that provides “grandkids on demand” to
Read More
Mon Ami Lands $3.4M to Tackle Social Isolation in Aging with Companions
- Mon Ami raises $3.4M in seed funding led by Freestyle Ventures and Cowboy Ventures to tackle social isolation in aging.
- By pairing older adults with college students for social visits, Mon Ami's marketplace focuses on life enrichment, not just life extension and fills a much-needed gap in the home care service industry.
Mon Ami, a Palo Alto, CA-based digital health company tackling social isolation in aging, today announced the closing of its $3.4M seed financing led by Freestyle
Read More
Research: Apple Devices Could Detect Early Alzheimer’s Disease (AD) Dementia
Eli Lilly, Evidation Health, and Apple has released initial results from a feasibility study that reveals an iPhone, Apple Watch, iPad, and the Beddit sleep monitoring device, in combination with digital apps, may be able to differentiate people with mild cognitive impairment (MCI) and mild Alzheimer's disease dementia. The exploratory results were presented today at the Association for Computing Machinery's KDD conference in Anchorage, and are published on the conference website.Impact of
Read More
Washington University Alzheimer’s Study Adopts BYOD Technology for Clinical Trials & Observational Study
The Washington University School of Medicine in Saint Louis has selected Datacubed Health’s mobile platform has been selected to support worldwide studies for those at risk of Dominantly Inherited Alzheimer’s Disease, a rare form of early-onset Alzheimer’s Disease. The Linkt platform enables the collection of real-time data on sleep, diet and other biomarkers using a “bring your own device” (BYOD) study model.Datacubed Health’s app, platform and web-based portal will be used by scientists at the
Read More
IDx and Topcon Join Forces to Scale AI-based Diagnostic Platform in the U.S. Market
IDx, an AI diagnostics company, and Topcon, one of the world’s leading ophthalmic device manufacturers, have signed an exclusivity agreement that will allow the companies to scale delivery of AI-based diagnostic solutions in the U.S. market. As part of the agreement, is granted exclusive rights to IDx-DR system, an autonomous AI system that instantly detects diabetic retinopathy in fundus images, exclusively with Topcon NW400, an easy to use, robotic fundus camera. IDx-DR is an FDA-cleared
Read More
Cytox Collaborates with Mayo Clinic to Develop New Algorithms to Evaluate Genetic Based Approaches for Assessing Alzheimer’s Risk
Cytox, a precision medicine company focused on commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s has entered into a research collaboration with Mayo Clinic to test current and develop new proprietary algorithms relating to the diagnosis and prognosis of Alzheimer’s disease. Under the agreement Cytox will assess genetic risk for developing Alzheimer’s disease using its current commercially available approaches developed to run on the
Read More
